Table 2.
Summary of effects of IL-1β and TNFα with or without TGF-β1 on expression of Col I, MMP-1 and αSMA in M-ES-healthy, M-ES-endo, and Ectopic-ES.
M-ES-healthy | M-ES-endo | Ectopic-ES | ||||||
---|---|---|---|---|---|---|---|---|
IL-1β (pg /mL) :1–10 | TNFα (pg/mL) :10–1000 | IL-1β (pg/mL) :1–10 | TNFα (pg/mL) :10–1000 | IL-1β (pg/mL) :1–100 | TNFα (pg/mL) :10–1000 | |||
Col 1 | mRNA | TGF-β1(−) | N.S. | N.S. | N.S. | N.S. | ↑: 1 ↓: 100 | ↑: 10 ↓: 1000 |
TGF-β1(+) | N.S. | N.S. | ↑ | ↑ | ↓: 10–100 | ↓: 100–1000 | ||
protein | TGF-β1(−) | N.S. | N.S. | N.S. | N.S. | ↓: 100 | ↓: 1000 | |
TGF-β1(+) | N.S. | N.S. | N.S. | N.S. | ↓: 100 | ↓: 1000 | ||
MMP1 | mRNA | TGF-β1(−) | N.S. | N.S. | N.S. | N.S. | ↑: 10–100 | ↑: 100–1000 |
TGF-β1(+) | N.S. | N.S. | N.S. | N.S. | N.S. | N.S. | ||
αSMA | mRNA | TGF-β1(−) | N.S. | N.S. | N.S. | N.S. | ↓: 10–100 | ↓: 100–1000 |
TGF-β1(+) | N.S. | N.S. | N.S. | N.S. | ↓: 10–100 | ↓: 100–1000 | ||
protein | TGF-β1(−) | N.S. | N.S. | N.S. | N.S. | ↓: 10–100 | ↓: 100–1000 | |
TGF-β1(+) | N.S. | N.S. | N.S. | N.S. | ↓: 10–100 | ↓: 100–1000 |
Col I: collagen type I.
MMP-1: matrix metalloproteinase-1.
αSMA: alpha smooth muscle actin.
M-ES-healthy: menstrual endometrial stromal cells of healthy fertile women.
M-ES-endo: menstrual endometrial stromal cells of patients with endometriosis.
Ectopic-ES: endometriotic stromal cells.
N.S.: not significant.
According to the results of the present cell proliferation assays, effects of the highest dose of IL-1β (100 pg/mL) on cell migration, collagen gel contraction in M-ES-healthy and M-ES-endo were excluded for further analyses, due to markedly reduced cell viability.